ex-527 and Alzheimer-Disease

ex-527 has been researched along with Alzheimer-Disease* in 2 studies

Reviews

1 review(s) available for ex-527 and Alzheimer-Disease

ArticleYear
After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
    Bioorganic & medicinal chemistry, 2011, Jun-15, Volume: 19, Issue:12

    Class III histone deacetylases (sirtuins) are becoming increasingly recognized as important epigenetic drug targets in cancer and metabolic disorders. As key regulators involved in numerous cellular signalling pathways, sirtuins are also emerging as potential targets in various neurodegenerative diseases such as Alzheimer, Parkinson's disease and others, thus suggesting modulation of sirtuin activity could provide an interesting and novel therapeutic option. In particular, much attention has been raised by neuroprotective effects attributed to SIRT1 activation due to genetically induced sirtuin overexpression or administration of resveratrol, a natural compound found in the skin of red grapes and also in wine. Similarly, also sirtuin inhibitors display benefits in various neuropathologic disease models. In light of the growing interest in sirtuin modulation and with regard to the lack of conclusive data on small molecule activators of sirtuins this review recapitulates the known facts about sirtuins and their relevance in neurodegenerative diseases.

    Topics: Alzheimer Disease; Enzyme Inhibitors; Epigenesis, Genetic; Humans; Neurodegenerative Diseases; Parkinson Disease; Resveratrol; Sirtuins; Stilbenes; Up-Regulation

2011

Other Studies

1 other study(ies) available for ex-527 and Alzheimer-Disease

ArticleYear
Aβ-Induced Damage Memory in hCMEC/D3 Cells Mediated by Sirtuin-1.
    International journal of molecular sciences, 2020, Nov-03, Volume: 21, Issue:21

    It is well accepted by the scientific community that the accumulation of beta-amyloid (Aβ) may be involved in endothelial dysfunction during Alzheimer's disease (AD) progression; however, anti-Aβ anti-bodies, which remove Aβ plaques, do not improve cerebrovascular function in AD animal models. The reasons for these paradoxical results require investigation. We hypothesized that Aβ exposure may cause persistent damage to cerebral endothelial cells even after Aβ is removed (referred to as cerebrovascular endothelial damage memory). In this study, we aimed to investigate whether cerebrovascular endothelial damage memory exists in endothelial cells. hCMEC/D3 cells were treated with Aβ

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Carbazoles; Cells, Cultured; Endothelial Cells; Humans; Memory; Models, Theoretical; Plaque, Amyloid; Reactive Oxygen Species; Sirtuin 1

2020